IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vantage Consulting Group Inc

Q3 2024 Holdings

Filed 2024-11-14 | 4 holdings | $11.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Babcock & Wilcox Enterprises(BW)COM05614L209$4.9M2,416,20043.2%
Cibus Inc(CBUS)CL A COM STK17166A101$3.7M1,143,94932.7%
ADC Therapeutics SA(ADCT)SHSH0036K147$2.7M850,73723.5%
Fibrogen Inc(FGENEUR)COM31572Q808$78.2K195,7070.7%